Jerusalem, Israel

Eliyahu Gitman

This inventor holds 9 USPTO granted patents. Top assignee: Scalpal LLC. Active years: 2011-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eliyahu Gitman. Retrieved from https://idiyas.com/inventor/eliyahu-gitman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 8

Forward Citations = 124(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Eliyahu Gitman: Innovator in Medical and Dental Instruments

Introduction

Eliyahu Gitman is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical and dental instruments, holding a total of nine patents. His innovative designs have improved the functionality and usability of essential tools in healthcare.

Latest Patents

Among his latest patents are a handle for medical and dental scalpels and a scalpel tip. These inventions reflect his commitment to enhancing the precision and safety of surgical procedures. His work continues to influence the medical community positively.

Career Highlights

Eliyahu Gitman is associated with Scalpal LLC, where he applies his expertise to develop cutting-edge medical instruments. His career is marked by a dedication to innovation and a focus on improving patient care through better-designed tools.

Conclusion

Eliyahu Gitman's contributions to the field of medical and dental instruments demonstrate his innovative spirit and commitment to enhancing healthcare. His patents and work with Scalpal LLC highlight the importance of continuous improvement in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…